The proteomic approach in Parkinson's disease
Identifieur interne : 000F31 ( Main/Exploration ); précédent : 000F30; suivant : 000F32The proteomic approach in Parkinson's disease
Auteurs : Mauro Fasano [Italie] ; Bruno Bergamasco [Italie] ; Leonardo Lopiano [Italie]Source :
- PROTEOMICS – Clinical Applications [ 1862-8346 ] ; 2007-11.
English descriptors
Abstract
Parkinson's disease (PD) is a complex, multifactorial neurodegenerative disease affecting about 2% of the population over 65 years. Etiopathogenetic mechanisms of PD are not fully understood, although a number of factors contributing to the selective degeneration of substantia nigra neurons have been identified, including mitochondrial dysfunction, proteasomal impairment, oxidative stress, excitotoxicity, and inflammation. Although a global view of the disease at the molecular level can be obtained only from the biochemical analysis of the affected human tissue, difficulties in obtaining human specimens of the affected area have limited substantially the number of reports published to date. Therefore, cellular and animal models of the disease have been developed to investigate single factors contributing to disease pathogenesis, e.g., protein aggregation or altered dopamine homeostasis. In this review, we report how proteomic methodologies have been used so far to investigate cellular and animal models of PD, as well as to compare postmortem specimens of substantia nigra of affected patients to that of control subjects. Proteomic studies concur to highlight the role of a compromised antioxidant defense in PD pathogenesis. The proteomic approach in the investigation of etiopathogenetic mechanisms of PD is still at its beginning, however, the findings reviewed here should serve as a useful foundation to further work.
Url:
DOI: 10.1002/prca.200700264
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The proteomic approach in Parkinson's disease</title>
<author><name sortKey="Fasano, Mauro" sort="Fasano, Mauro" uniqKey="Fasano M" first="Mauro" last="Fasano">Mauro Fasano</name>
</author>
<author><name sortKey="Bergamasco, Bruno" sort="Bergamasco, Bruno" uniqKey="Bergamasco B" first="Bruno" last="Bergamasco">Bruno Bergamasco</name>
</author>
<author><name sortKey="Lopiano, Leonardo" sort="Lopiano, Leonardo" uniqKey="Lopiano L" first="Leonardo" last="Lopiano">Leonardo Lopiano</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:7A837BD80BFB27519C80B32A805703B255E2F15E</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1002/prca.200700264</idno>
<idno type="url">https://api.istex.fr/document/7A837BD80BFB27519C80B32A805703B255E2F15E/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">000A57</idno>
<idno type="wicri:Area/Main/Curation">000922</idno>
<idno type="wicri:Area/Main/Exploration">000F31</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The proteomic approach in Parkinson's disease</title>
<author><name sortKey="Fasano, Mauro" sort="Fasano, Mauro" uniqKey="Fasano M" first="Mauro" last="Fasano">Mauro Fasano</name>
<affiliation wicri:level="1"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Structural and Functional Biology and Centre of Neuroscience, University of Insubria, Busto Arsizio (VA)</wicri:regionArea>
<wicri:noRegion>Busto Arsizio (VA)</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bergamasco, Bruno" sort="Bergamasco, Bruno" uniqKey="Bergamasco B" first="Bruno" last="Bergamasco">Bruno Bergamasco</name>
<affiliation wicri:level="3"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neuroscience, University of Torino, Torino</wicri:regionArea>
<placeName><settlement type="city">Turin</settlement>
<region type="région" nuts="2">Piémont</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Salvatore Maugeri Foundation, IRCCS, Pavia</wicri:regionArea>
<wicri:noRegion>Pavia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lopiano, Leonardo" sort="Lopiano, Leonardo" uniqKey="Lopiano L" first="Leonardo" last="Lopiano">Leonardo Lopiano</name>
<affiliation wicri:level="3"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neuroscience, University of Torino, Torino</wicri:regionArea>
<placeName><settlement type="city">Turin</settlement>
<region type="région" nuts="2">Piémont</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">PROTEOMICS – Clinical Applications</title>
<title level="j" type="abbrev">Prot. Clin. Appl.</title>
<idno type="ISSN">1862-8346</idno>
<idno type="eISSN">1862-8354</idno>
<imprint><publisher>WILEY‐VCH Verlag</publisher>
<pubPlace>Weinheim</pubPlace>
<date type="published" when="2007-11">2007-11</date>
<biblScope unit="volume">1</biblScope>
<biblScope unit="issue">11</biblScope>
<biblScope unit="page" from="1428">1428</biblScope>
<biblScope unit="page" to="1435">1435</biblScope>
</imprint>
<idno type="ISSN">1862-8346</idno>
</series>
<idno type="istex">7A837BD80BFB27519C80B32A805703B255E2F15E</idno>
<idno type="DOI">10.1002/prca.200700264</idno>
<idno type="ArticleID">PRCA200700264</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1862-8346</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animal models</term>
<term>Brain proteomics</term>
<term>Cellular models</term>
<term>Parkinson's disease</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Parkinson's disease (PD) is a complex, multifactorial neurodegenerative disease affecting about 2% of the population over 65 years. Etiopathogenetic mechanisms of PD are not fully understood, although a number of factors contributing to the selective degeneration of substantia nigra neurons have been identified, including mitochondrial dysfunction, proteasomal impairment, oxidative stress, excitotoxicity, and inflammation. Although a global view of the disease at the molecular level can be obtained only from the biochemical analysis of the affected human tissue, difficulties in obtaining human specimens of the affected area have limited substantially the number of reports published to date. Therefore, cellular and animal models of the disease have been developed to investigate single factors contributing to disease pathogenesis, e.g., protein aggregation or altered dopamine homeostasis. In this review, we report how proteomic methodologies have been used so far to investigate cellular and animal models of PD, as well as to compare postmortem specimens of substantia nigra of affected patients to that of control subjects. Proteomic studies concur to highlight the role of a compromised antioxidant defense in PD pathogenesis. The proteomic approach in the investigation of etiopathogenetic mechanisms of PD is still at its beginning, however, the findings reviewed here should serve as a useful foundation to further work.</div>
</front>
</TEI>
<affiliations><list><country><li>Italie</li>
</country>
<region><li>Piémont</li>
</region>
<settlement><li>Turin</li>
</settlement>
</list>
<tree><country name="Italie"><noRegion><name sortKey="Fasano, Mauro" sort="Fasano, Mauro" uniqKey="Fasano M" first="Mauro" last="Fasano">Mauro Fasano</name>
</noRegion>
<name sortKey="Bergamasco, Bruno" sort="Bergamasco, Bruno" uniqKey="Bergamasco B" first="Bruno" last="Bergamasco">Bruno Bergamasco</name>
<name sortKey="Bergamasco, Bruno" sort="Bergamasco, Bruno" uniqKey="Bergamasco B" first="Bruno" last="Bergamasco">Bruno Bergamasco</name>
<name sortKey="Lopiano, Leonardo" sort="Lopiano, Leonardo" uniqKey="Lopiano L" first="Leonardo" last="Lopiano">Leonardo Lopiano</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F31 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000F31 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:7A837BD80BFB27519C80B32A805703B255E2F15E |texte= The proteomic approach in Parkinson's disease }}
This area was generated with Dilib version V0.6.23. |